Which Mechanism is Effective on the Hyperamylasaemia After Coronary Artery Bypass Surgery?

Algin H. I., Parlar A. I., YILDIZ İ., ALTUN Z. S., İŞLEKEL G. H., Uyar I., ...Daha Fazla

HEART LUNG AND CIRCULATION, cilt.26, sa.5, ss.504-508, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.hlc.2016.09.006
  • Dergi Adı: HEART LUNG AND CIRCULATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.504-508
  • Anahtar Kelimeler: Amylase, Coronary artery bypass grafting, Cystatin C, Hyperamylasaemia, Lipase, Renal dysfunction, CARDIOPULMONARY BYPASS, CARDIAC-SURGERY, POSTOPERATIVE HYPERAMYLASEMIA, ACUTE-PANCREATITIS, RISK-FACTORS, AMYLASE, COMPLICATIONS, SERUM
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background and Aim Acute pancreatitis is one of the less frequently diagnosed lethal abdominal complications of cardiac surgery. The incidence of early postoperative period hyperamylasaemia was reported to be 30-70% of patients who underwent coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB). The mechanism of pancreatic enzyme elevation after cardiac surgery is not clear. Our aim was to determine the relationship between ischaemia associated temporary renal dysfunction and elevation of pancreatic enzymes after CABG.